ESR1 and breast cancer: These data, along with studies that report 80% of BRCA1-related tumors are negative for ER and PR expression [19, 20], suggest that alterations in hormone signaling contribute to early stages of breast cancer development in histologically normal BRCA1mut/+ cells.